SCHEMBL10324226

SCHEMBL10324226

COC(=O)c1cccc(N(Cl)C(=O)c2cc3cnc(N4CCN(C(=O)OC(C)(C)C)CC4)nc3[nH]c2=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 1/20 0.43
▸ DYRK1A Q13627 2/20 0.39
▸ DYRK1B Q9Y463 2/20 0.39
▸ ACHE P22303 2/20 0.39
▸ DDB1 Q16531 1/20 0.38
▸ CRBN Q96SW2 1/20 0.38
▸ SMO Q99835 1/20 0.37
▸ NAMPT P43490 1/20 0.37
▸ GPR119 Q8TDV5 3/20 0.37
▸ KIT P10721 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MTOR P42345 1/20 0.36
▸ CCNK O75909 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CCND3 P30281 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ CDK6 Q00534 1/20 0.36
▸ CKS1B P61024 1/20 0.36
▸ SKP1 P63208 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10323582 0.86 DYRK1A (0.48) PTPN11DYRK1ADYRK1BACHEMAPT
SCHEMBL10324224 0.81 DYRK1A (0.62) PTPN11DYRK1ADYRK1B
SCHEMBL10323504 0.75 DYRK1A (0.43) DYRK1ADYRK1BCKS1BSKP1SKP2
SCHEMBL10323240 0.74 DYRK1A (0.47) DYRK1ADYRK1BNAMPTCDK2CKS1B
SCHEMBL10324514 0.74 DYRK1A (0.49) DYRK1ADYRK1B
SCHEMBL10323580 0.71 DYRK1A (0.67) DYRK1ADYRK1BSMN1; SMN2
SCHEMBL10323992 0.70 DYRK1A (0.46) DYRK1ADYRK1BCDK2
SCHEMBL3607189 0.69 GPR119 (0.57) PTPN11ACHEGPR119MAPTCKS1B
SCHEMBL10323269 0.68 DYRK1A (0.69) DYRK1ADYRK1B
SCHEMBL10324214 0.68 POLB (0.45) DYRK1ADYRK1BMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184542-A1 PYRIDO PYRIMIDINES TYMS, TYMP, DPYD PTPN11 2012/4885DYRK1A 654/4885DYRK1B 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback